I am really excited to be invited to take part with a number of patient advocates in a panel on November 3rd. The purpose of the panel as described by the FDA is "to facilitate the interaction of the FDA with the Type 1 and Type 2 diabetes communities to provide FDA with real-world perspectives as the agency deliberates complex policies that affect the safety and effectiveness of marketed products on which people with diabetes depend."
The agenda includes a set of presentations by FDA representatives and diabetes advocates followed by a set of two panels. The first, which I will be sitting on will include a number of well known diabetes advocates including our own Manny Hernandez. The second panel will turn things around and Kelly Close as a patient advocate will moderate a discussion among FDA representatives. The full agenda is on-line as well as the bios of all the speakers.
The whole meeting is going to be webcast on November 3, 1-4pm EST and I encourage you to attend. The invitation to the webcast is here and you are asked to register before the start of the session.
ps. And you may remember we posted about a survey for this meeting. Thanks to all those that took the time to respond to the survey from diaTribe for this meeting, over 5,000 responses were received and it will be presented at the meeting.